Home
Help
Search
Login
Register
Welcome,
Guest
. Please
login
or
register
.
National Amyloidosis Centre Patient Forum
»
Amyloidosis
»
Research
»
ARC requests approval of NT-proBNP as a biomarker in clinical trials
« previous
next »
Print
Pages: [
1
]
Go Down
Author
Topic: ARC requests approval of NT-proBNP as a biomarker in clinical trials (Read 5165 times)
patpinchin
Posts: 600
AL - extensive in skin. mouth + palatal nerves '04
ARC requests approval of NT-proBNP as a biomarker in clinical trials
«
on:
July 20, 2016, 07:38:18 pm »
Hi Miriam,
Encouraging news for cardiac patients. See link below.
If FDA approval is given for the use of NT-proBNP as a biomarker, is it likely to apply to the two current studies for NEOD001 at the NAC?
Is NT-proBNP an approved biomarker for clinical trials in the UK?.
http://finance.yahoo.com/news/amyloidosis-research-consortium-announces-publication-152700555.html
Logged
Pat
Miriam Vered
Administrator
Posts: 572
Re: ARC requests approval of NT-proBNP as a biomarker in clinical trials
«
Reply #1 on:
July 21, 2016, 09:02:13 am »
Professor Hawkins' answer: It remains to be seen how the FDA and EMA will view cardiac biomarkers as a trial endpoint, this ultimately being tested when the results of a trial are submitted to them.
Logged
patpinchin
Posts: 600
AL - extensive in skin. mouth + palatal nerves '04
Re: ARC requests approval of NT-proBNP as a biomarker in clinical trials
«
Reply #2 on:
July 21, 2016, 01:25:54 pm »
Thank-you Professor Hawkins and Miriam.
Logged
Pat
Print
Pages: [
1
]
Go Up
« previous
next »
National Amyloidosis Centre Patient Forum
»
Amyloidosis
»
Research
»
ARC requests approval of NT-proBNP as a biomarker in clinical trials